# Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-

> **NCT04595929** · NA · RECRUITING · sponsor: **St. Petersburg State Pavlov Medical University** · enrollment: 304 (estimated)

## Conditions studied

- Peritoneal Carcinomatosis
- Gastric Cancer

## Interventions

- **PROCEDURE:** Staging laparoscopy
- **DRUG:** 5-Fluorouracil
- **DRUG:** Leucovorin
- **DRUG:** Oxaliplatin
- **DRUG:** Docetaxel
- **PROCEDURE:** Radical surgery
- **PROCEDURE:** PIPAC
- **DRUG:** Adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04595929
- **Lead sponsor:** St. Petersburg State Pavlov Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-10
- **Primary completion:** 2021-10-10
- **Final completion:** 2029-01-10
- **Target enrollment:** 304 (ESTIMATED)
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595929, "Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04595929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*